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Summary. 
Delirium is prevalent among intensive care 
unit patients.  It prolongs length of stay, 
increases costs, and is independently 
associated with higher mortality rates.  While 
its specific biological pathways are largely 
unknown, environmental and iatrogenic 
determinants have been repeatedly 
recognized.  Removal of the known triggers 
and pharmacologic intervention constitute 
available therapies.  This review focuses on 
the clinical significance of delirium in 
critically ill patients, from its prevalence to its 
long- term impact, the ways that we have to 
diagnose it, and the available therapeutic 
options. 
 
Key Words:  ICU delirium; acute brain dysfunction; 
diagnosis of ICU delirium. 
Case report. 
Mr. B. O’ D. is a 63 year old patient who was admitted to 
the Veterans Administration Boston surgical intensive 
care unit (ICU) in May 2011 following a hepatic resection 
for metastatic colon carcinoma.  His comorbidity included 
hypertension, hyperlipidemia and post- traumatic stress 
disorder (PTSD).  His habitual medications consisted of 
anti- hypertensives, a statin, benzodiazepines, a serotonin- 
reuptake inhibitor, and a phenothiazine antipsychotic.  His 
six- hour intraoperative course was complicated by a 
blood loss estimated at 2- 3 liters, associated with several 
episodes of hypotension.  He was admitted to the ICU late 
in the day, planning to extubate his trachea in the morning 
when fully stabilized.  However, every attempt to wean 
sedative medications resulted in uncontrollable agitation: 
he was severely delirious.  A number of pharmacologic 
interventions were unsuccessfully attempted, including 
intravenous haloperidol and a continuous infusion of 
dexmedetomidine.  It was subsequently learned that the 
patient had been consuming for some time substantial 
doses of unprescribed benzodiazepines.  Subsequently, 
the combination of higher doses of lorazepam and an oral 
anti- psychotic allowed discontinuing continuous 
intravenous sedation.  After two failed tracheal 
extubations due to a combination of respiratory failure 
and delirium, a tracheostomy was performed.  The patient 
was eventually transferred to a rehabilitation facility after 
19 days of ICU and 5 additional days on the general ward, 
with a tracheostomy tube in place.  Mr. O’ D.’s case 
raises a number of relevant issues, including: 
1. Delirium prolonged his ICU course, and resulted 
in the need for a tracheostomy.  Overall, his 
hospital course was much longer than expected, 
and costs for his care were much higher than 
would have been otherwise for him, his family 
and society. 
2. Despite the violence of his delirium, he did not 
injure himself. 
3. The least recommended class of drugs for 
treating delirium, benzodiazepines, was 
instrumental for his clinical turn- around, 
although it did not resolve delirium per se. 
4. The newest and most expensive drug, 
dexmedetomidine, was inconsequential. 
5. A number of factors may have contributed to the 
onset of delirium, including hypotension, tracheal 
intubation, and benzodiazepine withdrawal.  
Although not reported in the literature to our 
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knowledge, one wonders about the role of PTSD 




Delirium can be a frightening experience for 
patients and their families.  In its most obvious 
manifestations of psychomotor agitation it can 
directly harm the patient and occasionally the 
caregivers. (1)  Its fluctuating character is such that 
patients have period of lucidity between attacks, and 
may vividly remember the nightmares and delusions 
that they experienced.  This striking feature is a 
likely contributor to the development of ‘post- ICU 
stress disorder’ that may haunt patients for years 
after the resolution of critical illness. (2)  Over the 
past decade, we have learned that delirium in ICU 
patients is associated with an increased morbidity, 
prolonged length of stay, long- term psycho- social 
harm, and possibly a higher mortality rate.  (3,4) This 
review focuses on the significance of delirium in 
critically ill patients, from its prevalence to its long- 
term impact, the diagnostic tools we have, and the 




Delirium is an acute and fluctuating impairment 
of attention, cognition, and behavior (Table 1). (5)  Each 
of these elements is key to the proper diagnosis.  Acute: 
delirium is a new and distinct event from any previous 
neuro- psychiatric pathology, such as dementia, neuroses, 
etc.  Fluctuating: delirious patients may experience 
breakthroughs of lucidity, they are mystified at what they 
realize happened to them, and they fear its recurrence.  
Repeated episodes of delirium may have similar cognitive 
characteristics, unique to each patient.  We do not have a 
definition of how long these lucid intervals have to be, to 
be no longer considered part of a single episode of 
delirium.  Attention: easy distractibility and difficulty in 
focusing on a simple task are common prodromes of the 
upcoming delirium.  Although these signs may be missed 
by the inexperienced or rushed clinicians, family 
members will often bring them to our attention.  
Cognition: impaired cognitive function can manifest both 
as the inability to recognize familiar persons or topics of 
conversation and as the onset of hallucinations and 
delusions that may become particularly elaborate as 
delirium progresses.  Behavioral alterations vary widely, 
from the classical psychomotor agitation that may cause 
harm, to a deceivingly calm state of fear, to behaviors 
unusual for each patient that may lead family members to 
assert that ‘they cannot recognize their relative’.  
 
Table 1.  Diagnostic elements of delirium. 
  
A disturbance of  
                   
Attention 
Difficulty focusing, easy 
distractibility 
                   
Cognition 
Disorganized thinking; incoherent 
speech; hallucinations; delusions 
                  
Behavior 
Agitation vs. lethargy; fear; 
paranoia; irritability 
That is  
                          
Acute 
Occurs over a few hours, 
sometimes with short- lived  
prodromes  
Fluctuating Lucid intervals between episodes, 
with memory of the events 
 
Delirium is prevalent among critically ill patients, 
particularly those that are intubated and mechanically 
ventilated.  In medical, surgical, and trauma ICUs, 
patients who undergo mechanical ventilation have a 
prevalence of delirium as high as 80%. (6)  The need for 
mechanical ventilation is likely a surrogate of severity of 
illness, but the tracheal intubation per se, as well as the 
tight fitting of a non- invasive ventilation mask, may 
produce sufficient distress (inability to talk, 
breathlessness, etc.) to trigger delirium.  It is important to 
note that most mechanically ventilated ICU patients are 
not hypoxemic and may have not been hypoxemic at the 
time of intubation; the implication that hypoxemia is a 
common trigger of ICU or perioperative delirium is not 
based on robust clinical evidence. (7). 
 
 
Etiology.  The cause of delirium often escapes 
the clinician, and it is likely to be multifactorial.  In 
patients who exhibit multiple known predisposing factors 
(see below) delirium may develop as a result of one 
Translational Medicine @ UniSa, - ISSN 2239-9747 2012, 2(1): 1-9 
 
3 
Università degli Studi di Salerno 
modifiable trigger, such as the absence of windows and 
daylight in an ICU cubicle.  Conversely, the occurrence of 
multiple potential triggers at the same time, such as the 
stresses of major surgery, general anesthesia, and the 
administration of opiates, may elicit delirium in a patient 
with no known predisposing factors. 
The biological bases of delirium are still largely 
unknown, but functional neuroimaging and other neuro- 
behavioral techniques are providing novel and often 
visual information on the activity of areas of the central 
nervous system involved in different types and phases of 
acute confusional states. (8)  A number of theories of the 
pathogenesis of delirium focus on neurotransmission, 
inflammatory response, and the role of acute injuries on a 
predisposed background. (9).  In this article, we will limit 
our review to the factors that are known to predispose to 
delirium and those that can be considered modifiable 
precipitating factors or ‘triggers’.  These include (Table 
2):  
Older age.  Patients above 65 years of age 
have a high incidence of delirium at all levels of 
hospitalization: 10 - 15% in the general ward, 15 - 
50% postoperatively, and nearly 90% in the ICU. (1)  
What makes the elderly more susceptible to delirium 
may include cardiovascular and metabolic 
comorbidity, the intake of large numbers of 
prescribed medications, a higher sensitivity to acute 
stress, surgery, and anesthetics, and the prevalence of 
dementia and other chronic neurologic diseases. 
Dementia. There seems to be a complex 
interaction between delirium and dementia.  As many as 
two- thirds of elderly patients developing delirium have 
baseline dementia. (10,11)  The progression of dementia 
seems to be accelerated by ICU delirium and 
postoperative delirium (also called ‘postoperative 
cognitive dysfunction’). (12)   
Severity if illness.  Delirium is not only more 
frequent in hospitalized patients with multiple 
medical problems, but it is often the early warning of 
the onset of a new complication, such as sepsis or 
congestive heart failure.  A number of studies have 
confirmed the statistical association of indices of 
severity of illness such as the Acute Physiology And 
Chronic Health Evaluation Score II (APACHE II) 
with the development of delirium. (13,14)  
Hip Fractures.  Elderly individuals undergoing 
surgical fixation of a hip fracture have a particularly high 
incidence of perioperative delirium, possibly related to 
their advanced age and organic disorders, but also to 
anemia, pain, surgery and anesthesia, and to analgesic 
medications. (12,15)  In this patient population, 
postoperative delirium is associated with a higher rate of 
dementia and mortality at 5 years.  
 
Acute, modifiable risk factors include: 
Hypoxemia and cerebral hypoperfusion.  It seems 
logical maintaining hemodynamic and metabolic stability 
throughout a stressful period, be it major surgery or a 
critical illness to support brain metabolism and function.  
However, except probably for extreme event such as a 
cardiac arrest, the etiologic role of hemodynamic 
instability as it may occur during complex surgery is not 
so clear.  A few studies have supported this relationship 
(15), others have not. (7) 
Benzodiazepines have been consistently 
associated with the onset of delirium, with no 
exception among individual drugs, and possibly in a 
dose- dependent fashion. (6,14,16)  However, they 
can be effective in special conditions.  They are the 
drug of choice in benzodiazepine- and alcohol- 
withdrawal syndromes.  In addition, they may be 
very valuable in severe hyperactive delirium, not to 
treat delirium per se, but to temporarily calm the 
patient and allow the implementation of other 
therapeutic measures.  
 
Opiates also have been consistently 
associated with delirium. (14,16)  Despite anecdotal 
reports of the contrary, there is no clear evidence of a 
- receptor agonist being different from another in 
triggering the onset of delirium.  Just like for 
benzodiazepines, whose anxiolytic and sedative 
effect may be beneficial for delirious patients, the 
analgesic and sedative effect of opiates also may be 
immediately beneficial.  However, these temporary 
advantages must be carefully balanced with the long- 
term effect on the patient mental status.  
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Table 2.  Factors involved in the development of 
delirium. 
  
Predisposing factors  
Older age > 65 years, and continues to 
increase beyond it  
Cognitive factors Dementia, chronic psychosis, 
stroke 
Functional status Bedridden, debilitating 
stroke, dependency 
General health status Visual and hearing 
impairment, malnutrition 
Chemicals Psychoactive drugs 
Multiple drugs 
Comorbidity Cardiac disease, hepatic 
failure, uremia, multiple 
conditions 
Precipitating factors  
Cerebral hypoperfusion Severe hypotension, ‘low 
flow’ states, shock, 
hypoxemia 
Acute stressors Sepsis, surgery, anesthesia, 
major trauma, high fever 
Withdrawal Alcohol, benzodiazepines, 
opiates, other drugs of abuse 
Benzodiazepines All drugs of this class.  Dose- 
dependent 
Opiates All agonists, and agonist- 




Impact of delirium.   
Delirium in the ICU has been consistently 
associated with an increased duration of mechanical 
ventilation, increased ICU and hospital stay, and a 
higher mortality rate. (2,12,14)  Recent findings also 
associate delirium to prolonged cognitive decline. (4) 
The obvious question is whether delirium causes 
these poor outcomes or it occurs in ICU patients that 
are particularly ill (see correlation with high 
APACHE II scores) and will naturally have a high 
rate of complications and death.  Several lines of 
thought support a causal role of delirium in the 
ultimate demise of critically ill patients.  First, 
delirious patients occasionally hurt themselves, 
through self- extubation, falls, etc.  However, it is 
unclear whether such episodic events are sufficient to 
aggravate the overall prognosis of delirium.  Second, 
delirious patients are exposed to the side effects of 
additional pharmacologic therapy, prolonged time on 
the ventilator, and may not participate in 
mobilization and physical therapy, leading inevitably 
to more nosocomial complications and, possibly, 
increased mortality.  Finally, delirium could be a 
sign and a cause of ‘brain failure’ or ‘acute brain 
dysfunction’ (6), which, like any other organ failure, 
will increase the overall odds against recovery and 
survival. (3)  However, as appealing as these views 
can be, they have only been supported by 
multivariate logistic regression analysis.  The 
definite demonstration that delirium kills patients 
necessitates a biological mechanism, and the 
evidence that proper diagnosis and treatment of 




Diagnosis.   
Diagnosing delirium is simple when the patient is 
agitated, delusional, and tirelessly resistant to reassurance 
and redirection.  This is the classical ‘hyperactive 
delirium’, but not the only face of delirium, and possibly 
not the most common.  Delirium is often subtle at the 
onset, when the patient becomes unable to focus on 
simple tasks such as memorizing a sequence of letters.  
However, he / she may already suffer of delusions that 
will reveal if skillfully probed.  That’s when our patient 
discloses in a whisper that a certain nurse ‘has been trying 
to kill him every night’ or that she must go home now ‘to 
attend to serious business matters’.  In certain patients, 
delirium remains quiet and devoid of any agitation.  This 
‘hypoactive delirium’ may be less frequently diagnosed 
because of its subtle manifestations, but is not less 
common; it seems more frequent in the elderly, and it has 
been repeatedly linked to a worse prognosis. (3,4,18)  
Most commonly, the same patient may alternate hyper- 
and hypoactive episodes (‘mixed’ delirium).  The 
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implication of a worse prognosis associated with one or 
the other subtype of delirium has to imply a different 
physiologic makeup, unless one hypothesizes that the 
hypoactive delirium is less frequently diagnosed and 
therefore less frequently treated, thus leading to an 
increased mortality.  However, this line of reasoning 
implies that: a) we have an effective treatment for ICU 
delirium, and b) delirium per se kills patients, but for 
neither point we have robust evidence.  Furthermore, the 
implication of a worse prognosis attached to hypoactive 
delirium has prompted vigorous calls for active seeking 
out delirium using systematically a validated diagnostic 
instrument as part of the routine nursing evaluation of all 
ICU patients. (3,18,19)  This practice may or may not be 
the best- fitting solution for all ICUs, as we suggest it 
could be prevented with a thorough education of the ICU 
staff (see below). 
It is clear that delirium is at least a complex and 
multifaceted syndrome that requires knowledge and 
experience to diagnose it.  To complicate things, the most 
severely ill ICU patients, i.e., those who primarily 
develop delirium, can be averbal due to airway intubation.  
For decades, the inability to communicate by voice 
impeded the availability of a reliable and valid diagnostic 
instrument of delirium in the ICU, hindering our 
understanding and treatment of these patients.  This came 
to an end with the development and validation of the 
Confusion Assessment Method for the ICU (CAM- ICU), 
a version of the already existing CAM applied to non- 
verbal ICU patients. (20)  Other diagnostic instruments 
for ICU delirium have been developed, but the only one 
that has reached widespread use is the Intensive Care 
Delirium Screening Checklist (ICDSC). (21)   
The CAM- ICU and the ICDSC are two similar 
scales, both developed on the diagnostic principles of 
DSM- IV (ref.) and both extensively validated.  The 
CAM- ICU is easy to administer, and its 4 steps are tied 
to each other, so that it is common to be done after step 1 
or 2. 
1
  The ICDSC contains more diagnostic criteria and 






4&context=G1f4c9AHTs_GGQAAAA  Both sites 
were accessed on December 4th, 2011. 
may be suited for the analysis of different manifestations 
of delirium (22) 
 
 
Figure 1.  The Confusion Assessment Method for 
the ICU (CAM-ICU), in the version used at the 
Massachusetts General Hospital Surgical ICU.  Courtesy 
of Houman Amirfarzan, MD.  
 
 
The ICDSC may also be less sensitive than the 
CAM-ICU. (23). A number of benefits have resulted from 
the availability of validated diagnostic instruments for 
delirium. 
1. Enhanced sensitivity.  We have a test that is 
much more sensitive than the empiric diagnosis of 
delirium available before.  For example, al patients 
with dementia or any pre-existed neuro- psychiatric 
condition (e.g., bipolar disorder) use to be excluded 
from studies of ICU delirium.  Since then, we have 
learned a great deal about the complex interaction 
between dementia and delirium, where the former 
may be a risk- factor for the latter, and the latter may 
accelerate the evolution of the former thus leading to 
an earlier severe dementia and need for 
institutionalization (see above, under ‘Etiology’). 
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Table 3.  Elements of the Intensive Care Delirium 
Screening Checklist (ICDSC) 
 Day 1 Day 2 Day 
3 
Altered level of consciousness *    
Inattention    
Disorientation    
Hallucinations, psychosis    
Psychomotor agitation or 
retardation 
   
Inappropriate speech, mood    
Altered sleep / wake cycle    
A. No response 
B. Response only to intense and repeated stimuli 
C. Response to mild / moderate stimuli 
D. Normal wakefulness 
E. Exaggerated response to normal stimuli 
NOTE: If A or B, the evaluation is not completed. 
 
2. Higher specificity.  Not all emotional / 
psychological manifestations of critical illness are 
delirium.  ICU patients are often in pain, anxious, 
‘disoriented’ in an unfamiliar and intimidating 
environment, weakened and frustrated by the lack of 
sleep, the noise, and the overall loss of control of an 
unfamiliar experience.  The administration of potent 
analgesic and sedative medications may temporarily 
affect memory and orientation, such that a patient 
may not always pass the time- honored ‘alert and 
oriented x 3’ test, or classic questions such as ‘who is 
the President of the United States?’.  Yet, one 
wonders about the relevance of such questions if 
applied to those us who are experiencing a frustrating 
age- related selective decrease in memory of, e.g., 
names and places; or, when we consider what 








3. The standardization of the diagnosis of 
delirium that can be easily used in different ICUs, 
under different circumstances, and even in different 
languages throughout the world. 
4. The opportunity of using delirium as a quality 
indicator.  Delirium is common, frequently 
iatrogenic, and intimately linked to the process of 
care.  As such, it is well- suited for use as a quality 
indicator. (24)  Accordingly, it has already been 
included in lists of markers of quality and patient 
safety, such as those of the National Quality 
Measures Clearinghouse of the Agency for 
Healthcare Research and Quality.
3




Treatment of delirium is still mainly 
symptomatic, as its underlying mechanism is often 
unidentified.  A thorough search for a modifiable cause 
should always be performed: hypoxemia, serum sodium 
imbalance, uremia, hepatic failure, intoxications, etc.  
Even when a predominant factor is not identified, which 
is common, a number of generic contributing factors can 
often be corrected (see under ‘Etiology’). 
Environmental and behavioral interventions.  
Predisposing factors specific to each patient include 
dementia, prior stroke or transient ischemic attack, 
depression, severe illness or multisensory 
impairment. Precipitating factors are related to 
external stimuli or insults such as major surgery, ICU 
stay, and sleep deprivation, multiple psychoactive or 
analgesic medications (Table 2). 
A number of studies of delirium in 
hospitalized, non- ICU patients, has shown the effect 
of interventions aimed at preventing delirium by 
addressing known stressors, (25) summoning expert 
help (26) and implementing educational programs. 
(27)  Recently, a similar study in concept tested the 
effectiveness of teaching and implementing 
interventions such as focused pain and analgesia 
management on a large cohort of ICU patients, 
resulting in superior patient comfort, shorter duration 
                                                                                                       
information-revolutions  Last accessed on 
December 4th, 2011. 
3 http://www.qualitymeasures.ahrq.gov  last 
accessed on December 4th, 2011 
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of mechanical ventilation, and a lower incidence of 
subsyndromal (i.e., mild) delirium. (28) 
Pharmacologic treatment.  Prophylaxis rather 
than treatment would be ideal for a syndrome that ‘feeds 
on its own progress’ to become more resistant to 
interventions, given the patients’ lack of cooperation and 
the frequent side effects of treatment.  Although some 
data exist on the (partial) effectiveness of administering 
haloperidol or risperidone to patients at risk for the 
development of delirium (postoperative in these studies) 
no large controlled studies have been done in the ICU.  
(29,30) 
First line of treatment of ICU delirium remains 
intravenous haloperidol, a butyrophenone antipsychotic 
recommended by guidelines of the Society of Critical 
Care Medicine, (19) and supported in surveys of 
intensivists and pharmacist. (31,32)  Yet, haloperidol is 
not approved for intravenous use by the Food and Drugs 
Administration, has not been shown in a properly 
controlled study to decrease the morbidity of delirium, 
and is marred with significant side- effects, particularly 
ventricular arrhythmia, characteristically Torsades de- 
points.  Close monitoring of the QT- interval during 
haloperidol is strictly recommended, although a precise 
safe range of duration of the QT- interval (corrected by 
the heart rate) has not been defined.  Most clinicians 
would like to discontinue the drug with a QT- correct 
above 400 msec., but other factors such as underlying 
arrhythmia, the baseline duration of the QT (often close to 
400 msecs. off haloperidol), and the presence of 
additional risk factors (quinolone antibiotics, amiodarone, 
hypomagnesemia) must all be taken in account.  (33)  
Extrapiramidal motor symptoms can also occur, but rarely 
in the acute, intravenous phase of therapy. 
Atypical antipsychotics such as olanzapine and 
quetiapine are also used both as prevention and as 
treatment of ICU delirium.  These drugs have similar 
effects to haloperidol, but are not available for 
intravenous use.  Similarly to haloperidol, they have not 
been tested on meaningful outcomes in large controlled 
trials, although some indication of their efficacy has been 
proven (34).  Atypical anti- psychotics are not devoid of 
severe side- effects.  Initially marketed as less prone to 
cause QT- interval abnormalities (35), this has still to be 
demonstrated properly.  In non- ICU patients, the onset of 
malignant ventricular arrhythmia and sudden death was at 
least the same with atypical as with traditional 
antipsychotics such as butyrophenones and 
phenothiazines. (36) 
Benzodiazepines (see under Etiology) are not 
recommended drugs to treat delirium, except as a 
temporary intervention to treat the severe psychomotor 
agitation of some patients.  Conversely, benzodiazepines 
remain the drugs of choice in alcohol-withdrawal 
delirium.  
Dexmedetomidine, a selective -2- adrenergic 
agonist, is a more recent option for delirium 
management.  Dexmedetomidine has the favorable 
profile of inducing mild sedation devoid of 
respiratory depression and seemingly producing a 
‘mind- clearing effect’ that is not seen in the 
traditional gamma-amino-butyrate- mediated 
sedatives like benzodiazepines and propofol.  
Contrarily to the antipsychotocs, dexmedetomidine 
has been studied in large randomized trials and has 
compared favorably versus lorazepam and 
midazolam by decreasing the onset and duration of 
delirium (37,6).  However, the effects of a 
widespread use of dexmedetomidine as prophylaxis / 
treatment of delirium are unknown.  Anecdotally, the 
response to the sedative and ‘mind- clearing’ effects 
of dexmedetomidine is erratic, frequently limited by 
its predictable side effects of hypotension and 
bradycardia.   
 
Conclusions.  Delirium is prevalent in the ICU.  It 
prolongs the stay of mechanically ventilated patients, 
increases healthcare costs, and its neuropsychological 
sequelae may last for months- to years.  We know a 
number of predisposing factors but we do not do a good 
job in eliminating them.  Treatment is still rudimental, 
with drugs that have significant toxicity or limited 
efficacy, and we still resolve to using restrains.  
Awareness of ICU providers to the clinical significance of 
delirium has improved.  Education rather than 
enforcement of untested practices (e.g., routine 
administration of a diagnostic scale) seem the logical 
approach. 
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